Trial | NCT00219960  Report issue

Official Title

The Effect of North American Ginseng on Blood Pressure in Individuals With Hypertension

  • Phase

    Phase 3

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    52
To determine the effect of North American ginseng on blood pressure in individuals with hypertension.
Ginseng lacks proper clinical scrutiny for its effect on blood pressure (BP), in spite of observational evidence linking its intake to hypertension. This should be addressed considering the potential overlap between the prevalence of ginseng use and hypertension.

We undertook a single centre, randomized, controlled, double-blinded, crossover trial to determine the effect of North American ginseng (NAG) on 24-hour BP and renal function. After a 4-week placebo run-in, we randomly assigned participants to NAG or placebo treatment for 12-weeks at a dose of 3g/day. This was followed by an 8-week washout, and a subsequent 12-week period in which the opposite treatment was consumed. At run-in, and at weeks 0 and 12 of each treatment period, participants were fitted with an ambulatory BP monitor to assess 24-hour BP and serum cystatin C was measured.
Study Started
Apr 30
2001
Study Completion
Oct 31
2003
Last Update
Sep 22
2005
Estimate

Drug North American Ginseng (Panax Quinquefolius)

Criteria 

Inclusion Criteria:

aged 18 to 85 years
hypertension as defined by the use of antihypertensive drugs or a seated systolic blood pressure greater than or equal to 140 mm Hg or a diastolic BP greater than or equal to 90 mm Hg at each of 3 pre-study visits.

Exclusion Criteria:

secondary hypertension
diabetes
kidney
liver disease
unstable angina
ginseng use for two months prior to or during the study
any changes in the type or dose of antihypertensive drugs one month prior to or during the study
No Results Posted